Knight Therapeutics, Inc. (GUD.TO)
12.06
+0.01
(+0.08%)
CAD |
TSX |
Nov 13, 16:00
Knight Therapeutics Market Cap : 1.185B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.185B |
| November 12, 2026 | 1.184B |
| November 11, 2026 | 1.182B |
| November 10, 2026 | 1.177B |
| November 09, 2026 | 1.140B |
| November 06, 2026 | 1.122B |
| November 05, 2026 | 1.136B |
| November 04, 2026 | 1.110B |
| November 03, 2026 | 1.107B |
| November 02, 2026 | 1.112B |
| October 30, 2026 | 1.107B |
| October 29, 2026 | 1.120B |
| October 28, 2026 | 1.111B |
| October 27, 2026 | 1.108B |
| October 26, 2026 | 1.142B |
| October 23, 2026 | 1.140B |
| October 22, 2026 | 1.149B |
| October 21, 2026 | 1.149B |
| October 20, 2026 | 1.125B |
| October 19, 2026 | 1.111B |
| October 16, 2026 | 1.084B |
| October 15, 2026 | 1.061B |
| October 14, 2026 | 1.042B |
| October 13, 2026 | 1.049B |
| October 09, 2026 | 1.064B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.054B |
| October 07, 2026 | 1.052B |
| October 06, 2026 | 1.035B |
| October 05, 2026 | 1.018B |
| October 02, 2026 | 1.014B |
| October 01, 2026 | 1.045B |
| September 30, 2026 | 1.040B |
| September 29, 2026 | 1.017B |
| September 28, 2026 | 1.009B |
| September 25, 2026 | 1.011B |
| September 24, 2026 | 992.06M |
| September 23, 2026 | 991.08M |
| September 22, 2026 | 1.011B |
| September 21, 2026 | 999.92M |
| September 18, 2026 | 1.007B |
| September 17, 2026 | 1.005B |
| September 16, 2026 | 983.22M |
| September 15, 2026 | 978.31M |
| September 14, 2026 | 984.20M |
| September 11, 2026 | 967.50M |
| September 10, 2026 | 955.72M |
| September 09, 2026 | 972.41M |
| September 08, 2026 | 972.41M |
| September 04, 2026 | 983.22M |
| September 03, 2026 | 986.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 116.01M |
| Bausch Health Cos., Inc. | 4.457B |
| Cipher Pharmaceuticals, Inc. | 360.13M |
| BioSyent, Inc. | 201.74M |
| Revive Therapeutics Ltd. | 6.535M |
Market Cap Related Metrics
| PE Ratio | 74.95 |
| PS Ratio | 2.111 |
| Price to Book Value | 1.490 |
| Price to Free Cash Flow | 10.31 |
| Price | 12.06 |
| Earnings Yield | 1.33% |
| Operating PE Ratio | 38.02 |
| Normalized PE Ratio | 47.86 |